| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cheif Financial Officer | Chief Financial Officer
2 companies
Bibring Yoram is a Chief Financial Officer at BCLI, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $174K at current prices.
Bibring Yoram's largest disclosed position is in BCLI as Chief Financial Officer, worth about $152K. Net of sales, the recent Form 4 record there shows accumulation of 50,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | MRAI Marpai, Inc. | Cheif Financial Officer | Buy | 5,000 | $4.33 | $21,650.00 | New | |
| Aug 20, 2015 | BCLI Brainstorm Cell Therapeutics Inc. | Chief Financial Officer | Buy | 8,500 | $3.04 | $25,840.00 | +20.5% | |
| Aug 17, 2015 | BCLI Brainstorm Cell Therapeutics Inc. | Chief Financial Officer | Buy | 41,500 | $2.92 | $121,180.00 | New |